Introduction: Prior research suggests the CHRNA5A3B4 and CHRNB3A6 gene clusters have independent effects on smoking progression in young smokers. Here classification tree analysis uncovers conditional relations between these genes. Methods: Conditional classification tree and random forest analyses were employed to predict daily smoking at 6-year follow-up in a longitudinal sample of young smokers (N = 480) who had smoked at least one puff at baseline and were of European ancestry. Potential predictors included gender, lifetime smoking, Nicotine Dependence Syndrome Scale (NDSS), and five single nucleotide polymorphisms (SNPs) tagging CHRNB3A6 and CHRNA5A3B4 Haplotypes A, B, and C. Conditional random forest analysis was used to calculate variable importance. Results: The classification tree identified NDSS, the CHRNB3A6 SNP rs2304297, and the CHRNA5A3B4 Haplotype C SNP rs6495308 as predictive of year 6 daily smoking with the baseline NDSS identified as the strongest predictor. The CHRNB3A6 protective effect was contingent on a lower level of baseline NDSS, whereas the CHRNA5A3B4 Haplotype C protective effect was seen at a higher level of baseline NDSS. A CHRNA5A3B4 Haplotype C protective effect also was observed in participants with low baseline NDSS who had no CHRNB3A6 rs2304297 minor allele.
Introduction
The CHRNA5A3B4 and CHRNB3A6 gene clusters, which are composed of CHRN* genes that encode nicotinic cholinergic receptor (nAChR) subunits, 1, 2 have been reliably associated with smoking in adults. [3] [4] [5] [6] [7] [8] [9] [10] Resequencing of CHRNA5A3B4 in European-derived populations identified a linkage disequilibrium block comprising four haplotypes. 8 In adult smokers, Haplotypes A and B are associated with increased smoking risk whereas Haplotype C is associated with reduced risk. 3, [8] [9] [10] Consistent with findings in adult smokers, CHRNB3A6 and CHRNA5A3B4 Haplotype C have been associated with reduced smoking risk in adolescent smokers. 11 In young smokers, the evidence for an increased smoking risk of CHRNA5A3B4 Haplotype A is mixed. Two studies report a risk effect, 12 ,13 but we previously reported null effects for both Haplotypes A and B. 11 The mechanisms by which CHRNB3A6 and CHRNA5A3B4 Haplotype C affect smoking progression in young smokers remain to be identified, but preclinical rodent studies have shown that the nAChR subunits encoded by CHRNA5A3B4 and CHRNB3A6 play different roles in nicotine effects in brain. Specifically, the α6 subunit encoded by CHRNA6 has been implicated in nicotine positive reinforcement. 14 In contrast, the α5, α3, and β4 subunits encoded by CHRNA5A3B4 have been shown to modulate aversive effects of nicotine 15, 16 and to influence a satiety signal at nicotine doses that are not clearly aversive. 17 Further, rodent models suggest that α5 response to aversive nicotine effects occurs at a higher dose than necessary for nicotine positive reinforcement. 15 Joint actions of the CHRNA5A3B4 and CHRNB3A6 subunits in the same receptor subtype may also affect physical signs of nicotine withdrawal. 18 To extrapolate these preclinical findings to young smokers, it is possible that the protective effect of CHRNB3A6 is due to reduced nicotine positive reinforcement whereas the protective effect of CHRNA5A3B4 Haplotype C results either by modulating the aversiveness of higher nicotine doses, by increasing the satiety effects of lower doses, or by affecting withdrawal symptoms. By this line of reasoning, CHRNB3A6 effects would be predicted at lower nicotine doses or lower levels of Nicotine Dependence (ND) than would CHRNA5A3B4 effects. To our knowledge, such differences in the effects of these gene clusters on smoking progression in young smokers have not been reported. In a previous study in which we used a linear mixed model to estimate single nucleotide polymorphism (SNP) effects on smoking progression, we concluded that CHRNA5A3B4 Haplotype C and CHRNB3A6 had orthogonal, additive protective effects. 11 That conclusion does not support the hypothesis being proposed here, but our analytic method was not optimal for finding conditional genetic relations.
In this study, we employ binary recursive partitioning (BRP) methods, specifically classification trees and random forest, 19 to identify possible conditional relations between CHRNA5A3B4 and CHRNB3A6 effects on smoking progression. Recursive partitioning approaches have been suggested as alternatives to regression methods for detecting heterogeneity and interactions within multiple genes that individually associate with a phenotype. 20 Advantages of classification trees over common approaches like regression models include their ability to deal with collinear and multidimensional data. Specifically, BRP is able to detect complex interaction effects. 21, 22 Here we use BRP methods to investigate the hypothesis that CHRNB3A6 effects occur at lower nicotine doses or lower levels of ND than do CHRNA5A3B4 effects.
Methods

Sample and Procedures
Participants in the current study come from the Social Emotional Contexts of Adolescent Patterns (SECASP) study. [23] [24] [25] SECASP is a longitudinal study of 1263 adolescents recruited from the 9th and 10th grades of Chicago-area schools. Because the overarching aim of SECASP is to examine smoking progression rather than either smoking initiation or ND, participants who had ever smoked but were not yet daily smokers were oversampled. Assessments were made at baseline, 6, 15, 24, and 33 months, and then annually from years 4 to 6. During the year 5 or 6 assessments, participants were invited into the genetic arm of the project, and 1019 (81% of the original cohort) participated.
For this analysis we limited the sample (N = 480) to those participants who at baseline had smoked at least one puff and were of European ancestry as determined by a cluster analysis of 64 ancestry informative markers. 23 Eighty-nine percent (89%) self-identified as non-Hispanic white, 6% as Hispanic, and 5% as other race/ethnicity. Sixty percent (60%) were female. Mean age at baseline was 15.7 years (SD = 0.66).
Measures
Phenotypes
Smoking Quantity/Frequency. At each measurement wave, participants were asked how many days they had smoked cigarettes during the past 30 days, as well as the number of cigarettes typically smoked on days on which smoking occurred during the past month.
Year 6 Daily Smoking. Year 6 daily smoking was defined as smoking on all of the past 30 days at the time of the year 6 assessment. Daily smoking at year 6 was reported by 31% of participants.
Lifetime Smoking. Estimates of lifetime smoking at baseline were obtained using a question that grouped responses into the following categories: never smoked or smoking a puff, 1 cigarette, 2 to 5 cigarettes, 6 to 15, 16 to 25, 26 to 99, 100 to 500, and more than 500 cigarettes. At baseline, 14% of selected participants reported having smoked no more than one puff and 21% reported having smoked more than 100 cigarettes in their lifetime. These categories were re-coded into a continuous measure using the mid-point values. The last category of more than 500 cigarettes was re-coded into 600 cigarettes. The baseline report of number of cigarettes smoked lifetime was used both as a selection criterion (at least 1 puff required) and as a predictor of year 6 daily smoking.
Nicotine Dependence Syndrome Scale. The Nicotine Dependence Syndrome Scale (NDSS) 26 was used to assess smoking dependency. The modified version of the NDSS for adolescents 27 retained items reflecting drive and tolerance from the original NDSS scale. The mean NDSS score at baseline was 1.34 (SD = 0.71).
Genotyping
Genomic DNA isolation and SNP genotyping were carried out as previously described. 11 The tag SNP for the CHRNB3A6 protective effect was rs2304297, minor allele frequency = 0.23, and the clustering of haplotypes using rs2304297 as the tag SNP is shown in Supplementary Figure S1 . The tag SNPs and minor allele frequencies for CHRNA5A3B4 Haplotypes A and B were as follows: Haplotype A, rs16969968, 0.32; and Haplotype B, rs514743, 0.37. Two SNPs were entered in the model for Haplotype C: rs569207 and rs6495308. The minor allele frequency of both was 0.24, and their linkage disequilibrium (r 2 ) was 0.95. The clustering of CHRNA5A3B4 haplotypes using rs6495308, rs514743, and rs16969969 as tag SNPs is shown in Supplementary Figure S2 . The first Haplotype C tag SNP, rs569207, was the Haplotype C SNP used in our previous study. 11 The second, rs6495308, was identified in a meta-analysis as the top association signal within the protective haplotype at the CHRNA3 locus, 4 and therefore may be a more consistent tag SNP for Haplotype C. Entering both in the model afforded an opportunity to determine which was more predictive of daily smoking at year 6.
Analysis Strategy
Conditional classification tree analysis, as implemented in the R package party, 28 was used to predict daily smoking at the 6-year follow-up. Potential predictors included gender, baseline lifetime smoking, baseline NDSS, and the five SNPs.
Conditional trees overcome two fundamental problems of the classical classification methods: overfitting and selection bias toward covariates with many possible splits. 28 In this method, the conditional distribution of statistics measuring the association between the outcome and covariates is used. The method is based on permutation test theory and uses hypothesis testing for variable selection as a stopping criterion and therefore does not rely on pruning. After a classification tree is constructed, an estimate of the class probabilities for each terminal node is estimated as the relative frequencies of the responses. For the conditional tree analysis, a p value of .05 adjusted for multiple comparisons by Bonferroni correction was selected as a cut point for significant association. We also restricted the split in the terminal nodes to 20 observations or more, which further controls for overfitting.
Conditional random forest analysis was used to calculate variable importance-the ranked relevance of each covariate. Random forests are an ensemble method with improved predictive performance over a single classification tree. Random forest algorithm comes with its own built-in test samples which provide means of error estimation. Conditional random forest analysis is an alternative random forest method that provides unbiased variable selection in the individual classification trees. We used the default settings of 1000 random trees and four random variables, which have been shown to produce unbiased random forests. 29 Additional analyses were undertaken to further characterize the differences in year 6 smoking phenotypes by terminal node of the classification tree. Specifically, pair-wise contrasts between terminal nodes in year 6 daily smoking, NDSS, and cigarettes per day (CPD) were examined. Logistic regression analysis was used for daily smoking, linear regression model for the NDSS, and a ZIP model was used for CPD due to the high prevalence of zero CPD responses. Bonferroni adjustment was used for the logistic regression and ZIP analyses (10 contrasts, so .005 was the significance level). Tukey-adjusted post hoc tests were used for the linear model. Finally, logistic regression models were used to provide additional information about a SNP × SNP interaction observed in the classification tree results. Figure 1 presents the results of the conditional classification tree predicting daily smoking at the 6-year follow-up. The classification tree identified NDSS, rs2304297, and rs6495308 as predictive of year-6 daily smoking. The first split on NDSS at 1.83 as determined by the classification tree algorithm indicates that baseline NDSS was the strongest predictor of daily smoking at the 6-year follow-up. The further splits selected distinct SNPs conditional on the baseline NDSS value. The tree splits on presence/absence of CHRNB3A6 rs2304297 minor alleles among the low NDSS group (Node 2), and on CHRNA5A3B4 rs6495308 minor alleles in the high NDSS group (Node 7). The classification tree further improved on daily smoking prediction by splitting the left branch of Node 2 on rs6495308 (Node 3). Therefore, using three predictors and specifying four nodes, the classification tree had five terminal nodes. Conditional tree for predicting daily smoking measured at 6 years follow-up, N = 480. Potential predictors included gender, baseline lifetime smoking, baseline Nicotine Dependence Syndrome Scale (NDSS), and five single nucleotide polymorphisms (SNPs): rs2304297, rs6495308, rs569207, rs16969968, and rs514743. Bars depict predicted probability of daily smoking, with darker shade representing probability of "Yes" and lighter shade representing probability of "No. "
Results
To characterize terminal nodes more completely, pair-wise contrasts of those nodes were made for several smoking phenotypes (Table 1 ). Relative to other terminal nodes, Nodes 5 and 6 both had low daily smoking frequency, Nodes 4 and 9 both had intermediate daily smoking frequency, and Node 8 had high daily smoking frequency. A similar ranking of differences among terminal nodes was observed for the NDSS and CPD. Given that baseline NDSS was the strongest predictor of year 6 daily smoking, as well as a setting condition for differential genetic effects, phenotypic differences between the left and right branches of the tree are important to consider. At year 6 the right branch had a higher frequency of daily smoking (68%) than did the left branch (23%), chi-square (df = 1) = 69.8, p = 6.45E-17, and a higher NDSS score (M = 2.71, SD = 0.82) than did the left branch (M = 2.00, SD = 0.88), F(1,320) = 39.4, p < .0001. Thus, the rs2304297 effect was observed in a path characterized by low year 6 daily smoking and by low NDSS at both baseline and year 6, whereas the primary rs6495308 effect was seen at higher levels of year 6 daily smoking and higher NDSS at both the beginning and end of the study. A secondary rs649538 effect was observed with low baseline NDSS but intermediate year 6 daily smoking and intermediate year 6 NDSS and no rs2304297 protective allele. Figure 2 presents results of the conditional random forest analysis, listing the ranked variable importance. NDSS is the strongest predictor of 6-year daily smoking, followed by lifetime cigarettes measured at baseline, followed by SNPs rs6495308, rs569207 and rs2304297. Neither CHRNA5A3B4 Haplotype A (rs16969968), CHRNA5A3B4 Haplotype B (rs514743), nor gender was a notable predictor of the outcome. Maximizing on the total of sensitivity and specificity by applying Youden's J statistic, 30 the optimal threshold was 34%. Using the optimal threshold and cross-classification of true versus predicted daily smoking at 6 years, the estimated sensitivity and specificity were 0.67 and 0.79, respectively, reflecting moderate levels.
Lifetime cigarettes reported at baseline and rs569207 both are ranked highly in the conditional random forest analysis, but neither appears in the classification tree because each is statistically redundant with another variable that was selected for the tree (see Boulesteix et al. 31 for similar example of this type of effect). Baseline lifetime cigarettes and baseline NDSS are highly correlated, r = 0.75, p < .001, but baseline NDSS was the better predictor of daily smoking at year 6. Likewise, the two CHRNA5A3B4 Haplotype C tag SNPs rs6495308 and rs569207 are in high linkage disequilibrium (0.95), but rs6495308 was the better predictor of the outcome variable.
Because smoking levels in the interval between smoking initiation and baseline were lower than levels post-baseline (data not reported), we queried rs2304297 and rs6495308 associations with the correlated smoking phenotypes: baseline NDSS and baseline lifetime cigarettes. These analyses constitute secondary but independent tests of the hypothesis that CHRNB3A6 protective effects occur at lower smoking levels than do CHRNA5A3B3 Haplotype C effects. In these analyses, the rs2304297 minor allele predicted lower lifetime cigarettes, β = −27.4, p = .04, but rs6495308 did not, p = .52 (Supplementary Figure S3) . Neither SNP predicted baseline NDSS, ps > .14. Thus, the baseline lifetime cigarette results provide additional support for the hypothesis.
The asymmetrical presence of rs2304297 and rs6495308 in the left and right branches of the tree indicates a SNP x SNP interaction effect. 31 To further examine this interaction, a series of logistic regression models were tested in which year 6 daily smoking was the outcome. Classification tree nodes and the NDSS were not included in these models to isolate the SNP effects. Preliminary analyses suggested that results based on additive and dominant (0 or 1, depending on the presence of at least one minor allele) SNP coding were equivalent. Thus, dominant-model coding was used to maintain sufficient cell size in tests of simple main effects and to be consistent with the SNP cut-points selected by the classification tree. In a two-SNP model, there was a SNP × SNP interaction, p = .02. Pair-wise contrasts of possible SNP allelic combinations indicated daily smoking frequency was highest in the absence of a minor allele for either SNP, p < .0003 (Figure 3) . No contrasts between pairs in which either or both SNPs contained a minor allele were significant.
Discussion
Consistent with results of our previous regression-based linear mixed-effects model analyses, 11 here we demonstrate that both CHRNA5A3B4 Haplotype C and the CHRNB3A6 SNP rs2304297 reduce smoking progression in adolescent and young adult smokers. However, our present findings uncover two novel conditional relations involving these genes. The first is that the protective effects of these SNPs are conditional on different baseline NDSS levels. Specifically, the rs2304297 protective effect is contingent on a lower baseline NDSS, whereas the primary CHRNA5A3B4 Haplotype C protective effect is seen at a higher baseline NDSS level. The second conditional relation was between genetic markers such that CHRNA5A3B4 Haplotype C protective effect also was observed in participants with low baseline NDSS conditional on the absence of CHRNB3A6 rs2304297 protective alleles. These findings highlight the ability of BRP methods to identify complex associations. Our hypothesis that CHRNB3A6 effects occur at lower nicotine doses or lower levels of ND than do CHRNA5A3B4 effects is supported by the finding that rs2304297 was prepotent in the left branch of the tree but rs6495308 was the only predictive SNP in the right branch. The right branch was characterized by higher smoking frequency, CPD, and ND (as measured by the NDSS). Further, only the CHRNB3A6 SNP was protective for the number of cigarettes smoked prior to baseline. Thus, we demonstrate in young smokers, for the first time to our knowledge, differential effects of CHRNB3A6 and CHRNA5A3B4 Haplotype C that are consistent with preclinical studies on corresponding nAChR subunits. However, we cannot conclude based on our data whether nicotine dose or avoidance of withdrawal is more important to this differential genetic effect. Clearly, further research would be needed to answer that question.
There is indirect support in older adults for the proposition that CHRNB3A6 and CHRNA5A3B4 Haplotype C protective effects are contingent on level of cigarette use. Although both CHRNA5A3B4 and CHRNB3A6 gene clusters consistently show the strongest GWAS associations with smoking quantity in adult populations, 7 CHRNA5A3B4 haplotypes are consistently the top signals with a CPD phenotype. However, in one cohort with an excess of "light" nondependent smokers (Fagerstrom Test of Nicotine Dependence = 0), the effect of CHRNB3A6 was comparable to that of CHRNA5A3B4. 32 Our use of random forest analysis for predicting year 6 daily smoking showed higher ranked variable importance of CHRNA5A3B4 over CHRNB3A6 haplotypes, suggesting divergent contributions of the protective alleles. The differential effects observed in our adolescent cohort may foreshadow these shifts in genetic effect sizes as the phenotype progresses through increasing levels of nicotine intake. Logistic regression analyses further characterize the interaction between CHRNA5A4B4 Haplotype C and CHRNB3A6 in the prediction of year 6 daily smoking. The minor allele of either SNP was sufficient to decrease the probability of daily smoking and having minor alleles for both SNPs did not further reduce the probability of daily smoking. This is a novel example of duplicate dominant epistasis, where duplicate gene action provides alternative genetic determination of a specific phenotype; in this case, the dominant protective effects of either CHRNA5A4B4 Haplotype C or CHRNB3A6 on year 6 daily smoking.
The current analysis assessed baseline and year 6 smoking phenotypes but was agnostic with respect to the interval between those two endpoints. Thus, we cannot determine whether different longitudinal patterns of smoking progression are typical of these two genetic markers. An analysis of genetic associations with smoking trajectory from adolescence to young adulthood would shed light on this question.
As was the case with our regression-based linear mixed-effects model analyses, neither CHRNA5A3B4 Haplotype A (rs16969968) nor Haplotype B (rs514743) were differentially associated with smoking progression, which is at variance with other reports of a Haplotype A effect in young smokers. 12, 13 These null effects in the present study do not identify the reason for the discrepancy in the findings of a Haplotype A effect in those studies, but they do suggest it is not dependent on the specific statistical methods we have used. Given the low smoking quantity/frequency and low NDSS scores even at year 6 in our cohort (Table 1) , our null results for Haplotype A in this adolescent cohort are consistent with a model where the CHRNA5A3B4 risk conferred by the α5 rs16969968, p.Asp398Asn allele (Haplotype A) is revealed at higher levels of nicotine exposure, consistent with mouse models that demonstrate higher nicotine intake with reduced α5 receptor function. The Haplotype C protective effect tagged by both the CHRNA5 SNP rs569207 and the CHRNA3 SNP rs6495308 (linkage disequilibrium = 0.95) is consistent with the protective effect seen with adult smoking quantity phenotypes, suggesting a core haplotype block that most likely includes the noncoding features conferring differential control of the CHRNA5A3B4 coding regions. In the present analysis, rs6495308 was the better predictor of smoking progression.
Limitations
The current findings cannot be generalized to other genetic ancestries. BRP methods are data-driven methods and so a somewhat small change in the data might result in a different tree structure. Thus, the lack of a replication cohort in this study is a limitation, but the inclusion of a random forest analysis mitigates this limitation. That is, the random forest analysis overcomes the sensitivity of classification tree analysis to the effects of sampling error on the chosen cut-points. Additionally, random forest has built-in cross-validation for calculation of the prediction error. In situations when linear regression assumptions are satisfied, BRP methods are outperformed by regression analysis. Nevertheless, BRP can offer advantages over Figure 3 . Frequency of year 6 daily smoking by dominant coding of rs6495308 (rs649D = 0 for homozygous major allele and 1 if there were a minor allele) and rs2304297 (rs239D = 0 for homozygous major allele and 1 if there were a minor allele). Pair-wise contrasts indicated daily smoking frequency was higher in the absence of a minor allele for both single nucleotide polymorphisms (SNPs) than in the presence of either minor allele, p < .0003. No contrasts between pairs both containing minor alleles were significant.
linear regression models and provide a complementary approach to uncovering complex associations.
Conclusions
The protective effects of CHRNA5A3B4 Haplotype C and CHRNB3A6 rs2304297 on smoking progression are conditional on baseline cigarette use, with the former gene cluster conditional on higher use, whereas the latter is conditional on lower use. This pattern of findings is consistent with preclinical research on the effects of nAChR subunits on nicotine reinforcement and withdrawal. Also, an epistatic interaction between SNPs indicated the minor allele of either SNP afforded comparable protective effects in the absence of a minor allele at the other locus. These findings demonstrate that classification trees can uncover relations among genetic markers not obvious in regression models and so encourage further use of these methods to better parse the complex set of relations among genetic and nongenetic variables that influence smoking progression.
Supplementary Material
Supplementary Figures S1-S3 can be found online at http://www.ntr. oxfordjournals.org
Funding
This research was supported by the National Cancer Institute of the National Institutes of Health under award number (P01CA098262). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.
Declaration of Interests
None declared.
